Riley E Mclean-mandell, MD | |
281 Lincoln St, Worcester, MA 01605-2138 | |
(508) 334-8494 | |
(508) 334-5232 |
Full Name | Riley E Mclean-mandell |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 11 Years |
Location | 281 Lincoln St, Worcester, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588002273 | NPI | - | NPPES |
110115483A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 273502 (Massachusetts) | Primary |
207N00000X | Dermatology | 255710 (Massachusetts) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
Scientists in the United States have developed a new technology that reduces the time it takes to achieve a detailed diagnosis of avian flu, from one week or more down to less than 12 hours.
The interactions between proteins and nucleic acids play a critical role in some of life's most crucial biochemical processes, including gene expression and protein production, and some promising anticancer agents exert their effects by interfering with these interactions.
Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a leader in developing minimally-invasive Ear, Nose & Throat technologies, today announced the U.S. commercial launch of TruDi, a real-time, three-dimensional navigation system for ENT procedures performed in the operating room and surgeon office.
The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.
› Verified 2 days ago
Entity Name | Umass Memorial Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
Scientists in the United States have developed a new technology that reduces the time it takes to achieve a detailed diagnosis of avian flu, from one week or more down to less than 12 hours.
The interactions between proteins and nucleic acids play a critical role in some of life's most crucial biochemical processes, including gene expression and protein production, and some promising anticancer agents exert their effects by interfering with these interactions.
Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a leader in developing minimally-invasive Ear, Nose & Throat technologies, today announced the U.S. commercial launch of TruDi, a real-time, three-dimensional navigation system for ENT procedures performed in the operating room and surgeon office.
The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Riley E Mclean-mandell, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Riley E Mclean-mandell, MD 281 Lincoln St, Worcester, MA 01605-2138 Ph: (508) 334-8494 |
News Archive
Scientists in the United States have developed a new technology that reduces the time it takes to achieve a detailed diagnosis of avian flu, from one week or more down to less than 12 hours.
The interactions between proteins and nucleic acids play a critical role in some of life's most crucial biochemical processes, including gene expression and protein production, and some promising anticancer agents exert their effects by interfering with these interactions.
Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a leader in developing minimally-invasive Ear, Nose & Throat technologies, today announced the U.S. commercial launch of TruDi, a real-time, three-dimensional navigation system for ENT procedures performed in the operating room and surgeon office.
The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.
› Verified 2 days ago
Jeremy S Bordeaux, MD MPH Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln Street, Umass Dermatology Hahnemann Campus, Worcester, MA 01605 Phone: 508-334-5971 | |
Mariko Yasuda, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Dermatology Residency, Worcester, MA 01605 Phone: 508-334-5971 | |
Dr. Ryan M Svoboda, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Kaitlyn Yim, MD Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Zoe Brown-joel, MD Dermatology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
John E Harris, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 | |
Sarah K Whitley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-5979 |